Public notice

Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).

관리자 │ 2023-01-17

HIT

856

Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).

 

The publication, titled, “3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury” may be found here (10.3390/ijms22158276 ).




Previous Post The therapeutic efficacy results of a candidate immunomodulatory imide drug deve...
Next Post Role of chronic neuroinflammation in neuroplasticity and cognitive function: A h...